Concepedia

Lasse Lehtonen

LL

65

Publications

4.8K

Citations

32

H-Index

1986

Active since

Affiliations

Helsinki University Hospital(Current)

Orion Corporation (Finland)

University of Helsinki

Hospital District of Helsinki and Uusimaa

University of Eastern Finland

Lasse Lehtonen is an author at Helsinki University Hospital specializing in medicine, pharmacology, and pharmacotherapy.

ORCID

Top concepts

Publications per year

1986–2023

65

Publications

65

Efficacy and safety of intravenous levosimendan compared with dobutamine in severe low-output heart failure (the LIDO study): a randomised double-blind trial

Ferenc Folláth, H. Just, JGY Papp et al. · The Lancet · 2002 · 1.2K citations

, , +10

Hemodynamic and neurohumoral effects of continuous infusion of levosimendan in patients with congestive heart failure

Markku S. Nieminen, Juha Akkila, Franz X. Kleber et al. · Journal of the American College of Cardiology · 2000 · 383 citations

, , +6

Sustained Hemodynamic Effects of Intravenous Levosimendan

Matti Kivikko, Lasse Lehtonen, Wilson S. Colucci · Circulation · 2003 · 255 citations

Pharmacokinetics of levosimendan and its metabolites during and after a 24-hour continuous infusion in patients with severe heart failure

Matti Kivikko, Saila Antila, Jaan Eha et al. · International Journal of Clinical Pharmacology and Therapeutics · 2002 · 198 citations

How to govern the digital transformation of health services

Walter Ricciardi, Pedro Pita Barros, Aleš Bourek et al. · European Journal of Public Health · 2019 · 186 citations · Full text

, , +16

Rows per page

1–5 of 65